PYR-41---Ubiquitin-activatingEnzymeE1Inhibitor
如果您對該產品感興趣的話,可以
產品名稱: PYR-41---Ubiquitin-activatingEnzymeE1Inhibitor
產品型號: M60201-2s
產品展商: 其它品牌
產品文檔: 無相關文檔
簡單介紹
PYR-41---Ubiquitin-activatingEnzymeE1Inhibitor
PYR-41---Ubiquitin-activatingEnzymeE1Inhibitor
的詳細介紹
Product Information
| Molecular Weight: |
371.30 |
| Formula: |
C17H13N3O7 |
| Purity: |
≥98% |
| CAS#: |
418805-02-4 |
| Solubility: |
DMSO up to 100 mM |
| Chemical Name: |
(Z)-ethyl 4-(4-((5-nitrofuran-2-yl)methylene)-3,5-dioxopyrazolidin-1-yl)benzoate |
| Storage: |
Powder: 4oC 1 year.
DMSO: 4oC 3 month;
-20oC 1 year. |
Biological Activity:
PYR-41 is a specific and cell permeable inhibitor of ubiquitin-activating enzyme E1 with an IC50 of < 10 uM, with no or little activity against E2. It blocks ubiquitylation and prevents ubiquitin-mediated proteasomal degradation. It inhibits NF-κB activation, blocks degradation of p53, increases p21 levels and induces apoptosis in vitro. PYR-41 can also cause an increase in sumoylation of proteins.
How to Use:
- In vitro: PYR-41 was used at 10-50 μM final concentration in various in vitro assays.
- In vivo: n/a
Reference:
- 1. Yang Y, et al. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. (2007) Cancer Res. 67(19):9472-81.
- 2. Kapuria V, et al. Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activity. (2011) Biochem Pharmacol. 82(4):341-9.
- 3. Ungermannova D, et al. Identification and mechanistic studies of a novel ubiquitin E1 inhibitor. (2012) J Biomol Screen. 17(4):421-34.
Products are for research use only. Not for human use.
